Discover key insights from Wynn Resorts' Q2 2025 earnings call, highlighting record-breaking Las Vegas performance, Macau growth, and progress on Wynn ...

Dynavax delivers record Q2 results with $92M in HEPLISAV-B revenue, updates 2025 guidance, and advances pipeline milestones.

CEO Basta reported Q2 revenue of $39.5 million, a 39% increase over Q1, and stated that the company ended the quarter with approximately $150 million in cash. He stated, "We believe our current cash ...

Gain insights into AvePoint's record-breaking Q2 2025 earnings, product innovations, and raised full-year guidance.

Catherine Walden Ramsey Schulte, Baird: Inquired about $250–$300 million revenue potential from Medicare coverage of noncovered indications. Chapman said, "a lot of upside opportunity from the ...

Warby Parker reports accelerated customer growth in Q2 2025, announces a Google AI eyewear partnership, raises guidance, and highlights retail & ...

Discover Amylyx Pharmaceuticals' Q2 2025 updates, including Avexitide's Phase III progress for PBH, upcoming PSP trial results, and a strong cash ...

Valvoline's growth strategy remains strong despite macroeconomic challenges. VVV stock has continued to expand the franchise ...

Discover Zai Lab's Q2 2025 earnings insights, featuring strong revenue growth, VYVGART momentum, profitability targets, and upcoming regulatory milestones.

CEO Michael Ryan Gorenstein stated that "Cronos Group's core business continues to perform well, driven by robust demand across key markets and product categories." He highlighted that net revenue ...